Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Chicago |
---|---|
Information provided by: | University of Chicago |
ClinicalTrials.gov Identifier: | NCT00203918 |
The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.
Condition | Intervention |
---|---|
Prostate Cancer |
Behavioral: Survey, interview |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Prostate Cancer Utilities and Cost-Effectiveness Analysis |
Estimated Enrollment: | 500 |
Study Start Date: | January 2004 |
The goal of this project is to incorporate patients' preferences into a previously developed prostate cancer treatment decision-model and to understand the implications for doing so for cost-effectiveness analysis. To do this, it is first necessary to obtain patient utility scores (i.e., patient preference weights). To do this we will perform a survey of patients visiting the urology clinic to undergo prostate biopsies to validate a method of utility assessment, and understand the patients' individual evaluations of treatment-related health studies. We will also ask patients questions relating to their anxiety levels concerning the possible diagnosis of prostate cancer.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Patients visiting the urology clinic at the University of Chicago.
Inclusion Criteria:
Exclusion Criteria:
Contact: David Meltzer, M.D., Ph.D. | 773-702-0836 | dmeltzer@medicine.bsd.uchicago.edu |
United States, Illinois | |
The University of Chicago | Recruiting |
Chicago, Illinois, United States, 60637 | |
Contact: David Meltzer, M.D., Ph.D. 773-702-0836 dmeltzer@medicine.bsd.uchicago.edu | |
Sub-Investigator: William Dale, M.D., Ph.D. | |
Sub-Investigator: Gregory Zagaja, M.D. |
Principal Investigator: | David Meltzer, M.D., Ph.D. | University of Chicago |
Responsible Party: | University of Chicago ( David Meltzer, MD, PhD ) |
Study ID Numbers: | 12843B |
Study First Received: | September 12, 2005 |
Last Updated: | March 25, 2009 |
ClinicalTrials.gov Identifier: | NCT00203918 History of Changes |
Health Authority: | United States: Institutional Review Board |
Prostate Cancer Cost-Effectiveness Analysis Utility Assessment |
Prostatic Diseases Genital Neoplasms, Male Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |
Neoplasms Neoplasms by Site Prostatic Diseases Genital Neoplasms, Male |
Urogenital Neoplasms Genital Diseases, Male Prostatic Neoplasms |